1. South Korea Stocks

  2. •

    Consumer non-durables

  3. •

    Food: specialty/candy
WOOSUNG CO. LTD.

WOOSUNG CO. LTD.

KKRX:006980
17,870.00
KRW
+80.00
(+0.45%)
543.82EPS
29.88P/E
42.15BMarket Cap
WOOSUNG CO. LTD.
KRX:006980
(Korea Stock Exchange)

Recent

price

17,870.00

P/E

ratio

29.88

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
154,973.38
148,385.75
152,574.59
138,976.41
131,104.2
122,221.65
106,748.69
108,108.59
112,772.93
132,658.59
151,118.02
187,101.88
238,009.36
247,314.63
236,181.18
238,834.25
247,476.86
Revenue per Share
3,710
5,523.34
2,770
1,220
1,590
-2,110
350
460
-1,610
4,640
2,241
-2,258
49
4,307
7,672
5,039
543.82
Basic EPS, GAAP
3,642.89
7,200.84
-135.7
1,354.93
3,843.73
-1,243.04
1,863.32
-10,426.18
-11,048.69
-3,500.22
3,320.33
-17,860.13
-1,253.63
-11,115.9
-2,280.55
11,530.44
8,693.56
Free Cash Flow per Basic Share
841.21
600
600.58
598.17
499.18
500.58
248.91
252.28
250.56
- -
150
150.19
149.65
- -
300.01
300
- -
Dividend per Share
59,307.16
64,536.79
66,060.99
66,900.81
67,845.19
64,708.53
64,416.2
64,402.44
61,977.13
67,439.57
68,992.84
67,106.2
67,490.63
71,109.03
77,988.83
81,930.71
78,430.96
Book Value per Share
59,302.47
64,468.61
65,992.69
66,831.73
67,774.21
64,636.87
64,345.54
64,351.25
61,953.31
67,415.83
68,963.02
67,075.25
66,715.06
70,494.51
77,151.94
81,317.11
77,929.07
Tangible Book Value per Share
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Basic Weighted Avg Shares
383,519
381,533
391,928
358,431
337,655
313,894
275,672
275,454
289,318
340,815
388,558
480,475
612,322
634,838
606,199
613,024
637,887
Sales/Revenue/Turnover
3.52
2.9
1.02
0.82
1.82
1.11
0.4
-0.69
-1.43
-1.05
1.16
0.19
-0.1
0.89
1.42
3.16
2.03
Operating Margin (%)
5,110
4,314
4,184
3,867
3,703
3,664
3,547
3,677
4,894
7,381
7,254
7,571
8,637
8,934
11,847
13,863
14,007
Depreciation Expense
9,181
14,202
7,115
3,146
4,095
-5,419
904
1,172
-4,130
11,921
5,762
-5,799
126
11,056
19,691
12,934
1,402
Net Income, GAAP
32.68
14.79
46.92
33.8
30.93
- -
62.45
42.13
- -
22.8
36.06
502.99
- -
17.41
- -
26.55
52.08
Effective Tax Rate (%)
2.39
3.72
1.82
0.88
1.21
-1.73
0.33
0.43
-1.43
3.5
1.48
-1.21
0.02
1.74
3.25
2.11
0.22
Profit Margin (%)
97,814
73,048
88,958
81,701
91,729
71,798
69,894
41,210
42,587
54,673
55,147
45,573
42,039
36,957
57,974
72,179
62,163
Working Capital
5,079
2,105
4,257
234
2,182
130
78
131
15,000
9,834
3,428
5,353
4,024
20,622
39,315
33,174
31,872
LT Debt
204,505
165,732
169,780
171,886
174,416
166,244
165,586
165,436
159,185
173,264
177,353
172,245
173,232
182,520
200,178
212,508
203,431
Total Equity
3.38
4.03
0.89
0.83
1.89
- -
0.21
-0.57
- -
-1.15
1.19
-1.53
- -
1.57
- -
4.09
1.7
Return on Invested Capital (%)
3.27
6.25
3.42
1.86
2.2
- -
0.66
0.89
- -
5.78
2.79
-3.88
- -
5.59
- -
4.99
1.24
Return on Capital (%)
6.17
8.92
4.24
1.84
2.36
-3.18
0.54
0.71
-2.54
7.16
3.29
-3.32
0.07
6.22
10.29
6.27
0.69
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
117,046
121,576
160,595
LT Borrowings
31,941
30,953
29,966
LT Finance Leases
1,233
1,788
1,906
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
41,630
52,913
42,149

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
280,421
278,706
314,993
Cash, Cash Equivalents & STI
79,214
67,628
104,277
Accounts Receivable, Net
95,819
94,212
91,735
Inventories
93,024
104,644
103,255
Total Current Liabilities
208,242
211,791
252,830
Payables & Accruals
- -
- -
- -
ST Debt
117,046
121,576
160,595
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.58%
3.78%
6.16%
Free Cash Flow
-178.99%
-126.12%
-605.61%
Net Income, GAAP
743.14%
1,682.22%
-34.32%
Sales/Revenue/Turnover
7.6%
10.28%
1.13%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
151,768
152,209
152,498
149,725
606,199
2025
139,253
148,454
162,271
163,045
613,024
2026
148,572
163,998
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-872
89
1,900
6,554.75
7,672
2025
329
1,709
1,569.26
1,431.21
5,039
2026
-1,277.12
-1,157
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
300.01
2025
- -
- -
- -
- -
300
2026
- -
- -
- -
- -
- -
Similar Companies
PepsiCo, Inc. (NASDAQ:PEP)
Britannia Industries Ltd (NSE:BRITANNIA)
Tata Consumer Products Limited (NSE:TATACONSUM)
The Hershey Company (NYSE:HSY)
Mondelez International, Inc. (NASDAQ:MDLZ)
Ulker Biskuvi Sanayi A.S. (BIST:ULKER)
Business
Woosung Co., Ltd. is a South Korean company primarily engaged in the manufacture and sale of compound animal feed for livestock, aquaculture, and pets, including feeds for pigs, poultry, cattle, fish, and companion animals. Founded in 1970 and headquartered in South Korea, the company operates in the formula feeds business, producing assorted mixed feeds with an annual production capacity exceeding 500,000 tons. Woosung also provides animal veterinary medicines and sanitation products, supporting the broader agricultural and farming industry. Its products and services target livestock farmers, fish farming operations, and pet food markets across South Korea and select international markets such as Vietnam and China. The company is listed on the Korea Stock Exchange under the ticker 006980.KS. Recent major changes include the rebranding from Woosung Feed Co., Ltd. to Woosung Co., Ltd., reflecting an expanded business scope beyond traditional feed products. Additionally, the company has advanced its product portfolio by launching new veterinary drug formulations and enhancing its feed production capabilities in response to rising demand. Woosung has also pursued strategic business support services, aiming to strengthen its operational efficiencies and customer engagement in the animal nutrition sector. These developments signify Woosung's ongoing commitment to innovation and growth in the animal feed and health industry within the Asia-Pacific region.